These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31167464)

  • 1. Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.
    Portales-Cervantes L; Dawod B; Marshall JS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31167464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions.
    Portales-Cervantes L; Haidl ID; Lee PW; Marshall JS
    J Innate Immun; 2017; 9(1):94-108. PubMed ID: 27806369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism.
    Burke SM; Issekutz TB; Mohan K; Lee PW; Shmulevitz M; Marshall JS
    Blood; 2008 Jun; 111(12):5467-76. PubMed ID: 18424663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of natural killer cells in antiviral immunity.
    Waggoner SN; Reighard SD; Gyurova IE; Cranert SA; Mahl SE; Karmele EP; McNally JP; Moran MT; Brooks TR; Yaqoob F; Rydyznski CE
    Curr Opin Virol; 2016 Feb; 16():15-23. PubMed ID: 26590692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Evasion of Natural Killer Cell Activation.
    Ma Y; Li X; Kuang E
    Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk between natural killer cells and mast cells in tumor angiogenesis.
    Ribatti D; Tamma R; Crivellato E
    Inflamm Res; 2019 Jan; 68(1):19-23. PubMed ID: 30132016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK Cell Hyporesponsiveness: More Is Not Always Better.
    Frutoso M; Mortier E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells as an initial defense against pathogens.
    Lodoen MB; Lanier LL
    Curr Opin Immunol; 2006 Aug; 18(4):391-8. PubMed ID: 16765573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bringing natural killer cells to the clinic: ex vivo manipulation.
    Childs RW; Berg M
    Hematology Am Soc Hematol Educ Program; 2013; 2013(1):234-46. PubMed ID: 24319186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell responses to viral infection.
    Brandstadter JD; Yang Y
    J Innate Immun; 2011; 3(3):274-9. PubMed ID: 21411975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells in antiviral defense: function and regulation by innate cytokines.
    Biron CA; Nguyen KB; Pien GC; Cousens LP; Salazar-Mather TP
    Annu Rev Immunol; 1999; 17():189-220. PubMed ID: 10358757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mast cells in viral infections].
    Witczak P; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():231-41. PubMed ID: 22706109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.
    El-Sherbiny YM; Holmes TD; Wetherill LF; Black EV; Wilson EB; Phillips SL; Scott GB; Adair RA; Dave R; Scott KJ; Morgan RS; Coffey M; Toogood GJ; Melcher AA; Cook GP
    Clin Exp Immunol; 2015 Apr; 180(1):98-107. PubMed ID: 25469725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling.
    Varudkar N; Oyer JL; Copik A; Parks GD
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mast cells in allergic inflammation.
    Amin K
    Respir Med; 2012 Jan; 106(1):9-14. PubMed ID: 22112783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cell Responses to Viruses and Pathogen Products.
    Marshall JS; Portales-Cervantes L; Leong E
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
    Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
    J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the threshold of natural killer cell responses.
    Narni-Mancinelli E; Ugolini S; Vivier E
    Curr Opin Immunol; 2013 Feb; 25(1):53-8. PubMed ID: 23270590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging roles for mast cells in host defence.
    Dawicki W; Marshall JS
    Curr Opin Immunol; 2007 Feb; 19(1):31-8. PubMed ID: 17126541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
    Cardamone C; Parente R; Feo GD; Triggiani M
    Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.